The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Misleading advertising for antidepressants in sweden: a failure of pharmaceutical industry self-regulation.

På svenska

Author

Summary, in English

The alleged efficacy of pharmaceutical industry self-regulation has been used to repudiate increased government oversight over promotional activity. European politicians and industry have cited Sweden as an excellent example of self-regulation based on an ethical code. This paper considers antidepressant advertising in Sweden to uncover the strengths and weaknesses of self-regulation.

Publishing year

2013

Language

English

Publication/Series

PLoS ONE

Volume

8

Issue

5

Document type

Journal article

Publisher

Public Library of Science (PLoS)

Topic

  • Health Care Service and Management, Health Policy and Services and Health Economy

Keywords

  • Advertising
  • Antidepressants
  • Drug Industry
  • Sweden
  • Codes of ethics

Status

Published

Project

  • After the success with the new generation antidepressants: Experiences, practices, discourses and changes in the self.

Research group

  • Cardiovascular Research - Immunity and Atherosclerosis
  • Diabetic Complications

ISBN/ISSN/Other

  • ISSN: 1932-6203